RT Journal Article
SR Electronic
T1 LATE-BREAKING ABSTRACT: Patient preference for display of electronic patient-reported outcomes in COPD clinical trials: Wording emphasis, question format, and navigation button placement
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP PA2898
DO 10.1183/13993003.congress-2016.PA2898
VO 48
IS suppl 60
A1 Laura Khurana
A1 Ellen M. Durand
A1 Sarah Tressel Gary
A1 Antonio V. Otero
A1 Chris Hall
A1 Aisling Ryan
A1 Christopher J. Evans
A1 Susan M. Dallabrida
A1 Valdo Arnera
YR 2016
UL http://erj.ersjournals.com/content/48/suppl_60/PA2898.abstract
AB Background: Electronic patient-reported outcomes (ePROs) are a reliable method for collecting data in clinical trials and offer many advantages over paper collection. It is essential to consider patient preference and ease of use when employing this technology. Improving the usability of ePRO in COPD clinical trials could reduce subject burden and improve engagement.Methods: 103 subjects with chronic obstructive pulmonary disease (COPD) were surveyed regarding their preferences for ePRO display.Results: Subjects thought that underlining (33%) and capitalization (33%) best drew attention to emphasized words on an ePRO screen. Subjects saw screens of a multi-select question displayed to the left of or above the answer options. 46% could read and understand the screens equally; of those with a preference, 63% preferred the top to bottom format. Subjects saw screens of a tablet ePRO device with one question per screen or several questions per screen. 54% preferred one question per screen because it was easier to read (66%) and easier to understand the question (41%). 46% preferred multiple questions per screen because it was easier to read (51%) and faster to complete (40%). Subjects were shown two screens with “back” and “next” navigation buttons at either the top or bottom of the screen. 24% thought it was equally easy to find the buttons; of those with a preference, 74% preferred them at the bottom.Conclusions: Trial sponsors should consider incorporating these patient preference results into the design of ePRO instruments, potentially reducing subject burden and increasing patient engagement in COPD clinical trials.